NUP42 Antibody

What is NUP42 and what is its primary function in cells?

NUP42 (also known as CG1 or NUPL2 in humans) is a nucleoporin protein that localizes asymmetrically to the cytoplasmic face of the nuclear pore complex (NPC). It plays a critical role in messenger RNA (mRNA) export from the nucleus to the cytoplasm. NUP42 contains two primary functional domains: a phenylalanine-glycine (FG) repeat domain that docks mRNP transport receptors, and a C-terminal domain that binds the DEAD-box ATPase activating cofactor Gle1 . Through these domains, NUP42 helps position mRNA protein particles (mRNPs) for terminal remodeling steps carried out by the DEAD-box ATPase Dbp5 (DDX19B in humans), which is essential for directional mRNA export . Studies have demonstrated that NUP42 functions as part of the machinery that facilitates the spatial coordination of mRNP remodeling during nuclear export .

How is NUP42 structurally organized and what domains are critical for its function?

NUP42 contains several distinct functional domains that contribute to its role in mRNA export:

• FG Repeat Domain: Located at the N-terminus, this domain contains phenylalanine-glycine repeats that dock mRNP transport receptors and facilitate targeting of mRNPs to the nuclear pore complex .

• Gle1-Binding Motif (GBM): Located within the C-terminal domain (CTD), specifically residues 408-424 in yeast (and a homologous region in humans), this highly conserved motif forms a high-affinity interaction with Gle1 with a measured KD of 0.0915 μM .

• C-Terminal Domain: Beyond the GBM, the CTD contains additional elements that contribute to NPC localization independent of Gle1 binding .

The minimal region of NUP42 required for Gle1 binding has been identified through localization studies in S. cerevisiae, showing that fragments containing residues 397-430 display nuclear rim staining consistent with NPC localization, while fragments containing only residues 410-430 do not properly localize .

How evolutionarily conserved is NUP42 across species?

NUP42 shows significant evolutionary conservation across eukaryotes, particularly in its functional domains. Structural and sequence analysis of NUP42 from multiple organisms reveals:

• GBM Conservation: The Gle1-binding motif is highly conserved from yeast to humans, with residues 408-424 in yeast NUP42 representing the most conserved region when analyzed by Clustal Omega alignment .

• Functional Conservation: The role of NUP42 in mRNA export is functionally conserved between yeast and humans. Studies have demonstrated that both yeast NUP42 and human NUP42 (hNup42) stimulate Gle1/hGle1B activation of Dbp5/DDX19B in similar manners .

• Structural Conservation: Crystal structures of Gle1- Nup42 from three organisms reveal an evolutionarily conserved binding mode, confirming the preservation of this interaction throughout evolution .

This conservation indicates the fundamental importance of NUP42's role in the essential process of mRNA export across eukaryotic organisms.

What techniques can NUP42 antibodies be effectively used for?

NUP42 antibodies can be employed in numerous experimental techniques:

• Immunofluorescence Microscopy: For visualizing NUP42 localization at the nuclear envelope rim. Fixed yeast cells can be processed with anti-NUP42 antibodies and detected with fluorophore-conjugated secondary antibodies (e.g., Alexa Fluor 488 or 594) .

• Western Blotting: For detecting NUP42 protein expression levels, mutations, or truncations. Cell lysates are separated by SDS-PAGE and blotted using specific anti-NUP42 antibodies, with visualization using fluorophore-conjugated secondary antibodies for quantitative analysis .

• Immunoprecipitation (IP): For studying protein-protein interactions with binding partners like Gle1. This technique is valuable for investigating how NUP42 interacts with the mRNA export machinery.

• Chromatin Immunoprecipitation (ChIP): For examining potential associations between NUP42 and chromatin regions involved in gene expression and mRNA processing.

• RNA Immunoprecipitation: For analyzing RNA molecules that associate with NUP42 during the mRNA export process.

When conducting these experiments, it's advisable to use antibodies validated for the specific technique and species being studied.

How can NUP42 antibodies help in studying mRNA export mechanisms?

NUP42 antibodies offer several methodological approaches for investigating mRNA export:

• Co-localization Studies: Combining NUP42 antibodies with probes for mRNA (such as oligo(dT) for poly(A)+ RNA) allows visualization of mRNA accumulation at nuclear pore complexes during export blockage . This can be performed using:

  • Fixed-cell immunofluorescence with anti-NUP42 antibody

  • FISH (fluorescence in situ hybridization) with Cy3-conjugated oligo(dT)

  • DAPI staining to visualize nuclei

• Protein Complex Analysis: NUP42 antibodies can immunoprecipitate NUP42 and associated proteins, allowing identification of components in the mRNA export machinery and how they are affected by mutations or cellular conditions.

• Functional Assays: Combining antibody-based detection with genetic manipulations (e.g., temperature-sensitive mutants) provides insights into how NUP42 facilitates mRNA export. For example, monitoring poly(A)+ RNA accumulation in nuclei when NUP42 function is compromised .

• Analysis of NUP42 Mutations: Antibodies that recognize specific domains of NUP42 can help determine how mutations affect protein localization, stability, and function in mRNA export.

What are the best fixation and permeabilization methods for immunostaining NUP42 at the nuclear pore complex?

For optimal immunostaining of NUP42 at the nuclear pore complex, consider these methodological recommendations:

• For Yeast Cells:

  • Fix cells in 3.7% formaldehyde for 10-60 minutes

  • Process specimens as described in Wente and Blobel (1993)

  • Permeabilize cell wall with zymolyase treatment

  • For co-staining, incubate with primary antibodies sequentially (e.g., anti-NUP42 followed by anti-NUP116)

  • Detect with fluorophore-conjugated secondary antibodies (Alexa Fluor 488/594)

  • Include DAPI (0.1 mg/ml) for nuclear visualization

• For Mammalian Cells:

  • Fix with 4% paraformaldehyde for 15 minutes at room temperature

  • Permeabilize with 0.2-0.5% Triton X-100 for 5-10 minutes

  • Block with 3-5% BSA or normal serum

  • For NPC rim staining, maintain mild fixation conditions to preserve epitope accessibility

  • Mount in anti-fade medium to preserve fluorescence

• Critical Considerations:

  • Overfixation can mask NUP42 epitopes, particularly those involved in protein-protein interactions

  • Test various fixation/permeabilization combinations to optimize signal-to-noise ratio

  • Include controls with known NPC markers (e.g., Nup159 in yeast) to confirm proper nuclear envelope staining pattern

How can NUP42 antibodies be used to investigate NUP42-Gle1 interactions in disease models?

NUP42 antibodies can be strategically employed to study NUP42-Gle1 interactions in disease contexts:

• Co-immunoprecipitation Assays:

  • Use anti-NUP42 antibodies to pull down protein complexes

  • Analyze co-precipitated Gle1 under normal and disease conditions

  • Quantify interaction strength through western blot analysis

  • Compare wild-type interactions with disease-associated mutations

• Proximity Ligation Assays (PLA):

  • Employ PLA to visualize and quantify NUP42-Gle1 interactions in situ

  • Compare interaction frequency/intensity between normal and disease states

  • Analyze spatial distribution of interactions relative to nuclear pore complexes

• Disease Model Applications:

  • Study mutations linked to motor neuron diseases, including ALS-associated Gle1 mutations

  • Analyze LCCS1 (lethal congenital contracture syndrome 1) mutations that affect hGle1 self-association and hGle1-hNup42 interaction

  • Investigate how disease mutations affect NUP42-Gle1 complex thermostability and function

• Thermostability Analysis Protocol:

  • Compare stability of wild-type vs. mutant NUP42-Gle1 complexes

  • Apply differential scanning fluorimetry techniques similar to those showing that disease mutations decrease Gle1 thermostability

  • Assess whether NUP42 binding can rescue Gle1 stability defects in disease mutants

Research has shown that mutations in human Gle1 associated with motor neuron diseases possess severe thermostability defects, suggesting that nucleoporin misfolding contributes to disease pathogenesis .

What methods can be used to investigate NUP42's role in mRNP remodeling at the nuclear pore complex?

To investigate NUP42's role in mRNP remodeling, researchers can employ these methodological approaches:

• RNA UV Cross-linking Experiments:

  • Apply UV cross-linking to capture direct RNA-protein interactions

  • Use NUP42 antibodies to immunoprecipitate cross-linked complexes

  • Analyze whether NUP42 mutations (e.g., nup42ΔFG) reduce mRNP remodeling capacity

  • Compare cross-linking efficiency between wild-type and mutant cells

• FG Domain Swap Experiments:

  • Create chimeric constructs replacing NUP42's FG domain with FG domains from other nucleoporins

  • Evaluate functionality through complementation assays and localization studies

  • Test whether specific FG domains are functionally equivalent or whether context matters

  • Analyze mRNA export efficiency in FG domain swap mutants

• Proximity-Dependent Labeling:

  • Fuse NUP42 to BioID or APEX2 for proximity-dependent labeling

  • Identify proteins and RNAs in close proximity to NUP42 during mRNA export

  • Compare labeling patterns between normal conditions and export blockage

• Single-Molecule Tracking:

  • Use fluorescently tagged mRNAs and high-resolution microscopy

  • Track mRNP particles as they interact with NUP42 at the nuclear pore

  • Measure residence times and export kinetics in wild-type vs. NUP42 mutant cells

Research has demonstrated that deleting both NUP42 and Nup159 FG domains results in cold-sensitive poly(A)+ mRNA export defects, indicating their cooperative role in mRNP positioning for remodeling by Dbp5 .

How can genetic interaction studies with NUP42 be designed and interpreted?

Designing and interpreting genetic interaction studies with NUP42 requires careful methodological consideration:

• Synthetic Lethality/Sickness Screening Protocol:

  • Create a query strain with NUP42 mutation (e.g., nup42ΔFG)

  • Cross with array of deletion or temperature-sensitive mutants

  • Score growth phenotypes to identify genetic interactions

  • Known interactions: nup42ΔFG nup159ΔFG shows synthetic genetic interactions with dbp5 and gle1 mutants

• Temperature Sensitivity Analysis:

  • Assess growth at various temperatures (16°C, 23°C, 30°C, 37°C)

  • Document growth curves in liquid culture:

    Strain	Doubling Time at 16°C	Doubling Time at 30°C
    Wild-type	~4-5 hours	~1.5-2 hours
    nup42ΔFG	Similar to WT	Similar to WT
    nup159ΔFG	Slightly increased	Similar to WT
    nup42ΔFG nup159ΔFG	Significantly increased	Similar to WT

• Rational Mutant Design:

  • Create domain-specific mutations based on structural data

  • Target the Gle1-binding motif (residues 408-424 in yeast)

  • Generate FG domain swaps to test domain specificity

  • Develop fusion constructs (e.g., Nup42 FG domain fused to Gle1 C-terminus)

• Interpretation Guidelines:

  • Synthetic lethality suggests parallel functional pathways

  • Cold sensitivity often indicates defects in macromolecular complex assembly

  • Consider both localization and functional consequences of mutations

  • Validate genetic interactions with biochemical and cell biological assays

Research has shown that fusing the Nup42 FG domain to the carboxy-terminus of Gle1 bypasses the need for the endogenous Nup42 FG domain, highlighting the importance of proximal positioning of these factors .

What are the most reliable methods to validate NUP42 antibody specificity?

Ensuring NUP42 antibody specificity is critical for experimental reliability. Implement these validation approaches:

• Genetic Controls:

  • Compare antibody signal between wild-type and NUP42 knockout/knockdown cells

  • Use cells expressing GFP-tagged NUP42 to confirm co-localization with antibody signal

  • Test antibody on cells expressing truncated NUP42 variants to confirm epitope specificity

• Immunoblot Validation:

  • Run lysates from cells expressing NUP42 variants with known molecular weights

  • Include negative controls (knockout/knockdown) and positive controls (overexpression)

  • Check for single bands of appropriate size with minimal non-specific binding

  • Validate with recombinant NUP42 protein as a positive control

• Peptide Competition Assay:

  • Pre-incubate antibody with excess immunizing peptide

  • Compare signal between blocked and unblocked antibody

  • Specific binding should be significantly reduced by peptide competition

• Cross-Species Reactivity Testing:

  • Test antibody against NUP42 from different species when studying conserved functions

  • Verify specificity using sequence alignment to predict cross-reactivity

  • Consider domain-specific antibodies when studying highly conserved regions

• Validation Protocol Example:

  Validation Method	Expected Result for Specific Antibody
  Western blot with WT lysate	Single band at ~42-45 kDa
  Western blot with NUP42 knockout	No band at target size
  IP-Mass Spec	NUP42 and known interactors (Gle1) identified
  IF with WT cells	Nuclear rim staining pattern
  IF with GFP-NUP42	Co-localization of antibody and GFP signals

What factors affect NUP42 antibody performance in different experimental contexts?

Several factors can influence NUP42 antibody performance across experimental applications:

• Epitope Accessibility Issues:

  • The FG domains of nucleoporins are intrinsically disordered and may adopt different conformations

  • NUP42's interaction with Gle1 may mask certain epitopes

  • Nuclear pore complex density can restrict antibody access in intact nuclei

  • Solution: Test different fixation protocols or use domain-specific antibodies

• Species and Isoform Specificity:

  • Human NUP42 (also known as CG1 or NUPL2) may have different epitopes than yeast Nup42

  • Alternative splicing or post-translational modifications may affect antibody recognition

  • Solution: Choose antibodies raised against conserved epitopes for cross-species studies

• Technical Considerations by Method:

  • Western Blotting:

    • Denaturing conditions may expose normally hidden epitopes

    • Reducing vs. non-reducing conditions can affect detection

    • Solution: Optimize SDS-PAGE conditions and transfer methods

  • Immunofluorescence:

    • Fixation method critically affects epitope preservation

    • Nuclear envelope preservation requires gentle permeabilization

    • Solution: Compare methanol vs. paraformaldehyde fixation

  • Immunoprecipitation:

    • Detergent selection affects protein-protein interactions

    • Salt concentration impacts complex stability

    • Solution: Use physiological buffers to maintain interactions

• Experimental Design Recommendations:

  • Include positive controls (GFP-tagged NUP42) in each experiment

  • Run parallel experiments with antibodies against known NPC components

  • Validate results with multiple antibodies recognizing different NUP42 epitopes

How can researchers optimize experimental conditions when using NUP42 antibodies to study mRNA export?

Optimizing experimental conditions for NUP42 antibody use in mRNA export studies requires attention to several methodological details:

• Temperature Considerations:

  • NUP42's role in mRNA export shows temperature-dependent phenotypes

  • Cold-sensitive defects (16°C) are particularly revealing for nup42ΔFG nup159ΔFG double mutants

  • Design temperature shift experiments (30°C → 16°C for 12 hours) to reveal conditional defects

  • Include temperature controls in live-cell imaging protocols

• RNA Visualization Optimization:

  • For in situ hybridization of poly(A)+ RNA:

    • Use Cy3-conjugated oligo(dT) at 1 ng/μl concentration

    • Include DAPI (0.1 mg/ml) for nuclear visualization

    • Process samples using established protocols (Wente and Blobel 1993)

• Combined Protein-RNA Analysis Protocol:

  • Fix cells using formaldehyde (3.7%) to preserve both protein and RNA

  • Perform RNA FISH first, followed by immunofluorescence

  • Include appropriate controls:

    Control Type	Purpose
    No antibody	Background fluorescence
    Secondary only	Non-specific binding
    Known NPC marker	Positive control
    Non-RNA export mutant	Specificity control

• Genetic Background Considerations:

  • NUP42 functions may be redundant with other nucleoporins

  • Combined mutations often reveal stronger phenotypes (e.g., nup42ΔFG nup159ΔFG)

  • ipk1Δ mutations (affecting IP6 production) enhance nup42Δ phenotypes

  • Consider genetic background effects when interpreting antibody staining patterns

• Live Cell vs. Fixed Cell Approaches:

  • For dynamic processes, use GFP-tagged NUP42 variants in live cells

  • For endpoint analysis, fixed cells provide better signal-to-noise ratio

  • Correlative approaches combining both can provide comprehensive insights

By implementing these optimized protocols, researchers can maximize the utility of NUP42 antibodies for investigating the complex mechanisms of mRNA export through the nuclear pore complex.

How might NUP42 antibodies be used to investigate links between nuclear transport defects and neurodegenerative diseases?

NUP42 antibodies can facilitate investigation of nucleoporin dysfunction in neurodegenerative diseases through several methodological approaches:

• Patient-Derived Sample Analysis:

  • Compare NUP42-Gle1 interactions in control vs. ALS patient-derived cells

  • Analyze NUP42 localization and complex formation in motor neuron disease models

  • Investigate whether disease-linked Gle1 mutations (shown to decrease thermostability) affect NUP42 binding and localization

  • Employ quantitative co-localization analysis with other NPC components

• Disease Mechanism Investigation:

  • Utilize NUP42 antibodies to track mRNP remodeling in neurodegenerative disease models

  • Measure mRNA export efficiency in cells expressing ALS-linked Gle1 mutations

  • Investigate whether NUP42 overexpression can rescue defects caused by Gle1 mutations

  • Assess whether nucleoporin misfolding contributes to disease progression

• Therapeutic Target Exploration:

  • Screen for small molecules that stabilize NUP42-Gle1 interactions affected by disease mutations

  • Develop assays using NUP42 antibodies to monitor restoration of mRNA export in disease models

  • Investigate whether enhancing NUP42 binding can rescue Gle1 thermostability defects

• Experimental Design Template:

  Disease Model	Analysis Methods	Expected Outcomes
  ALS patient iPSC-derived motor neurons	IF, IP, mRNA export assays	Altered NUP42-Gle1 localization, reduced complex formation
  LCCS1 cellular models	Thermostability assays, structural analysis	Decreased stability of NUP42-Gle1 complex
  Huntington's disease models	Nuclear transport assessment	Impaired nucleocytoplasmic transport through NPCs

Research has shown that impairment of nucleocytoplasmic transport through the NPC has been linked to both Huntington's disease and amyotrophic lateral sclerosis (ALS) , making NUP42 a potentially valuable target for investigation.

What emerging technologies might enhance the application of NUP42 antibodies in nuclear transport research?

Emerging technologies promise to revolutionize how NUP42 antibodies can be applied in nuclear transport research:

• Super-Resolution Microscopy Applications:

  • Implement STORM/PALM imaging to resolve individual NPCs (~120 nm diameter)

  • Map precise NUP42 positioning within the asymmetric structure of the NPC

  • Compare spatial relationships between NUP42 and other cytoplasmic filament nucleoporins

  • Analyze nanoscale changes in NUP42 distribution under different cellular conditions

• Engineered Antibody Formats:

  • Develop nanobodies against NUP42 for live-cell applications with minimal steric hindrance

  • Create bifunctional antibodies that simultaneously target NUP42 and interaction partners

  • Design split-fluorescent protein complementation systems for visualizing NUP42 interactions

  • Produce domain-specific antibodies for distinguishing functional regions of NUP42

• Advanced Proteomics Integration:

  • Combine NUP42 antibody-based proximity labeling with mass spectrometry

  • Implement multiplexed epitope detection to simultaneously track multiple nucleoporins

  • Apply quantitative interaction proteomics to measure changes in NUP42 binding partners

  • Develop FRET/BRET sensors using NUP42 antibody-derived binding domains

• CRISPR-Based Methodologies:

  • Create endogenously tagged NUP42 cell lines for antibody validation

  • Generate domain-specific knockins to distinguish FG domain vs. Gle1-binding functions

  • Develop cellular models with specific disease-associated mutations

  • Implement CUT&RUN or CUT&Tag approaches for studying chromatin associations

These technologies will enable researchers to investigate the complex functions of NUP42 in nuclear transport with unprecedented precision and detail, potentially revealing new aspects of mRNA export regulation and disease mechanisms.